Inventor
OSHLACK BENJAMIN
US157 patents
⚠️ This page may combine multiple inventors who share the name “OSHLACK BENJAMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PURDUE PHARMA LP
25 patentsUS9526724B2Dec 27, 2016
Controlled release hydrocodone formulations
PURDUE PHARMA LP56 citations99
US9060976B2Jun 23, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP72 citations99
US9044435B2Jun 2, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP55 citations99
US9040084B2May 26, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP38 citations99
US9034376B2May 19, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP48 citations99
US8999961B2Apr 7, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP41 citations99
US8871265B2Oct 28, 2014
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP51 citations99
US8647667B2Feb 11, 2014
Controlled release hydrocodone formulations
PURDUE PHARMA LP81 citations99
US8609683B2Dec 17, 2013
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP85 citations99
US8551520B2Oct 8, 2013
Controlled release hydrocodone
PURDUE PHARMA LP68 citations99
US8529948B1Sep 10, 2013
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP80 citations99
US8361499B2Jan 29, 2013
Controlled release hydrocodone formulations
PURDUE PHARMA LP54 citations99
US7842307B2Nov 30, 2010
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
PURDUE PHARMA LP221 citations99
US7658939B2Feb 9, 2010
Tamper-resistant oral opioid agonist formulations
PURDUE PHARMA LP176 citations99
US7514100B2Apr 7, 2009
Controlled release hydrocodone formulations
PURDUE PHARMA LP129 citations99
US6572885B2Jun 3, 2003
Orally administrable opioid formulations having extended duration of effect
PURDUE PHARMA LP264 citations99
US6316031B1Nov 13, 2001
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
PURDUE PHARMA LP96 citations99
US6294195B1Sep 25, 2001
Orally administrable opioid formulations having extended duration of effect
PURDUE PHARMA LP327 citations99
US6143353ANov 7, 2000
Controlled release formulations coated with aqueous dispersions of acrylic polymers
PURDUE PHARMA LP141 citations99
US6129933AOct 10, 2000
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
PURDUE PHARMA LP171 citations99
US6103261AAug 15, 2000
Opioid formulations having extended controlled release
PURDUE PHARMA LP346 citations99
US5968551AOct 19, 1999
Orally administrable opioid formulations having extended duration of effect
PURDUE PHARMA LP561 citations99
US5958459ASep 28, 1999
Opioid formulations having extended controlled released
PURDUE PHARMA LP388 citations99
US9387174B2Jul 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP26 citations98
US9387173B2Jul 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP27 citations98
EURO CELTIQUE SA
22 patentsUS6733783B2May 11, 2004
Controlled release hydrocodone formulations
EURO CELTIQUE SA396 citations99
US6716449B2Apr 6, 2004
Controlled-release compositions containing opioid agonist and antagonist
EURO CELTIQUE SA252 citations99
US6706281B2Mar 16, 2004
Melt-extrusion multiparticulates
EURO CELTIQUE SA191 citations99
US6696088B2Feb 24, 2004
Tamper-resistant oral opioid agonist formulations
EURO CELTIQUE SA456 citations99
US6387404B2May 14, 2002
Immediate release tablet cores of insoluble drugs having sustained-release coating
EURO CELTIQUE SA220 citations99
US6335033B2Jan 1, 2002
Melt-extrusion multiparticulates
EURO CELTIQUE SA280 citations99
US6306438B1Oct 23, 2001
Stabilized sustained release tramadol formulations
EURO CELTIQUE SA207 citations99
US6210714B1Apr 3, 2001
Immediate release tablet cores of acetaminophen having sustained-release coating
EURO CELTIQUE SA239 citations99
US6024982AFeb 15, 2000
Immediate release tablet cores of insoluble drugs having sustained-release coating
EURO CELTIQUE SA323 citations99
US5965161AOct 12, 1999
Extruded multi-particulates
EURO CELTIQUE SA471 citations99
US5958452ASep 28, 1999
Extruded orally administrable opioid formulations
EURO CELTIQUE SA519 citations99
US5716611AFeb 10, 1998
Emollient antimicrobial formulations containing povidone iodine
EURO CELTIQUE SA155 citations99
US5681585AOct 28, 1997
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
EURO CELTIQUE SA291 citations99
US5639476AJun 17, 1997
Controlled release formulations coated with aqueous dispersions of acrylic polymers
EURO CELTIQUE SA2,177 citations99
US5580578ADec 3, 1996
Controlled release formulations coated with aqueous dispersions of acrylic polymers
EURO CELTIQUE SA507 citations99
US5500227AMar 19, 1996
Immediate release tablet cores of insoluble drugs having sustained-release coating
EURO CELTIQUE SA473 citations99
US5472712ADec 5, 1995
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
EURO CELTIQUE SA603 citations99
US5286493AFeb 15, 1994
Stabilized controlled release formulations having acrylic polymer coating
EURO CELTIQUE SA630 citations99
US5273760ADec 28, 1993
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
EURO CELTIQUE SA560 citations99
US4970075ANov 13, 1990
Controlled release bases for pharmaceuticals
EURO CELTIQUE SA364 citations99
US4861598AAug 29, 1989
Controlled release bases for pharmaceuticals
EURO CELTIQUE SA523 citations99
US4443428AApr 17, 1984
Extended action controlled release compositions
EURO CELTIQUE SA304 citations99
WRIGHT CURTIS
2 patentsOSHLACK BENJAMIN
1 patentShowing the top 50 of 157 patents by PatentIndex Score.